BBLG
Bone Biologics
BBLG
BBLG
4 hedge funds and large institutions have $1.83K invested in Bone Biologics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CS
1
Clear Street
New York
|
$556 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$455 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $806 | 200 | -1,624 | -89% |
|
|
CS
2
Clear Street
New York
| $556 | 138 | +138 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $455 | 113 | +113 | New |
|
4
Bank of America
Charlotte,
North Carolina
| $16 | 4 | -17 | -81% |
|
5
Geode Capital Management
Boston,
Massachusetts
| – | – | -24,204 | Closed |
|
|
SS
6
SBI Securities
Tokyo,
Japan
| – | – | -1 | Closed |
|